PAEDIATRIC CONSUMER HEALTH IN SINGAPORE

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Paediatric Consumer Health Faces Challenges

Growth Opportunities Remain

Paediatric Ibuprofen Shows Fastest Growth

Competitive Landscape

GlaxoSmithKline Leads Paediatric Consumer Health

Innovation in Paediatric Vitamins and Dietary Supplements

Category Data

Table 1 Sales of Paediatric Consumer Health by Category: Value 2013-2018

Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2013-2018

Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2018

Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2014-2018

Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2015-2018

Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2018-2023

Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2018-2023

Executive Summary

Modern Lifestyles Provide Fertile Ground for Consumer Health in Singapore

Convenience and Prevention Shaping Market Development

Intensifying Competition

Changing Character of Demand Affecting Distribution Landscape

Fast-paced Lifestyles To Exert A Growing Influence

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Sources

Summary 2 Research Sources

Paediatric consumer health continues to face challenges to growth. According to the Singapore Department of Statistics, the number of babies born in 2017 reached the lowest level since 2010. This is attributable to the rising number of people living alone, women delaying having children and the high cost of raising children in Singapore. The paediatric consumer health category is also being challenged as Singaporean parents becoming better informed about the potential side effects of various med...

Euromonitor International's Paediatric Consumer Health in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.